Calcitriol has been proven to mediate the chemopreventive function of growth inhibitors and effectively enhance the inhibitory effects of erlotinib (an anti-EGFR mAb) against tumour proliferation in a patient-derived xenograft model of HNSCC [200]. The gene discussed is EGFR; the disease is neoplasm.